HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brady, G Articles by Farrell, P J Search for Related Content PubMed PubMed Citation Articles by Brady, G Articles by Farrell, P J

Epstein–Barr virus and Burkitt lymphoma

Department of Virology, Faculty of Medicine, Imperial College, London, UK

Correspondence to:
Professor Paul J Farrell, Department of Virology, Faculty of Medicine, Imperial College, St Mary’s Campus, Norfolk Place, London W2 1PG, UK; p.farrell{at}imperial.ac.uk

Burkitt lymphoma (BL) is an aggressive B-cell malignancy with endemic, sporadic and immunodeficiency-associated variants. It has been known for many years that the fundamental transforming event in BL is the translocation of the MYC gene, and the events that bring about this translocation and those that allow cells to survive with the constitutive expression of MYC have been the subject of intense investigation. Epstein–Barr virus (EBV) infection, malaria, immunodeficiency and spontaneous, somatic mutation can all contribute to the origin and maintenance of this cancer and their mechanisms are the subject of this review.

This article has been cited by other articles:

				W. Lucchesi, G. Brady, O. Dittrich-Breiholz, M. Kracht, R. Russ, and P. J. Farrell Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2 J. Virol., August 1, 2008; 82(15): 7456 - 7466. [Abstract] [Full Text] [PDF]